CDNA
Caredx Inc (CDNA)
Healthcare • NASDAQ • $48.61+3.45%
- Symbol
- CDNA
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $48.61
- Daily Change
- +3.45%
- Market Cap
- $2.34B
- Trailing P/E
- 21.79
- Forward P/E
- 33.45
- 52W High
- $49.76
- 52W Low
- $11.27
- Analyst Target
- $52.33
- Dividend Yield
- N/A
- Beta
- 2.42
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a solution that identifies allograft rejection and type of rejection in kidney transplant biopsy tissue; …
Company websiteResearch CDNA on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.